PYPD - IPO Update: ACell Proposes $75 Million IPO Terms
Quick Take
ACell (ACLL) has filed to raise $75 million from the sale of its common stock, according to an amended registration statement.
The company develops and sells wound treatment systems for various tissue care applications.
ACLL was growing revenue sharply but has since felt the negative effects from the Covid19 pandemic.
The IPO appears reasonably valued and I believe the negative effects from Covid19 will be temporary, although may last through 2020.
Company & Technology
Columbia, Maryland-based ACell was founded to develop proprietary porcine urinary bladder matrix technologies to assist in